Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
24
Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser: Majedie Asset Management Limited
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):   The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:   Use a separate form for each offeror/offeree   TESCO PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e) Date position held/dealing undertaken:   For an opening position disclosure, state the latest practicable date prior to the disclosure 04 April 2017
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?   If it is a cash offer or possible cash offer, state "N/A" No  

 

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:   5p ord
    Interests Short positions
  Number % Number %
(1) Relevant securities owned and/or controlled: 252,769,117 3.09    
(2) Cash-settled derivatives:          
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:        
    TOTAL:   252,769,117   3.09    

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

 

 

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security Purchase/sale   Number of securities Price per unit
5p ord Purchase 247,981  185.2511
5p ord      
5p ord      
5p ord      

 

(b)        Cash-settled derivative transactions

 

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
           

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

 

(ii)        Exercise

 

Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit
           

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
         

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
  None  

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
  None  

 

(c)        Attachments

 

Is a Supplemental Form 8 (Open Positions) attached? NO

 

 

Date of disclosure: 05 April 2017
Contact name: Matthew Hambly
Telephone number: 0207 618 3900

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

The Chemical Industry and EPA: A Broken System?

Updated Category News Views 0

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 0

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 0

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 0

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 0

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 0

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 3

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 0

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading

Top 5 Most Recently Viewed Articles

Verizon Communications Options Activity Highlights and Insights

Updated Category News Views 136

Verizon Communications Options Activity Insights Investors have been keeping a close eye on Verizon Communications as recent activity indicates an intriguing trend. Notably, large investors have been exhibiting a bearish attitude towards Verizon Communications. Analyzing the Options Activity Upon reviewing the options history for Verizon Communications (VZ), we identified...

Continue Reading
Economic Insights: Dollar, Treasury ETFs, and Oil Market Trends

Updated Category News Views 478

The Dynamics of Today’s Economic Landscape The world of economics is continuously evolving, and this week has proven to be particularly eventful. From debates about the U.S. dollar's role in global finance to fluctuations in oil prices, there are many essential updates to consider. Let’s explore these pivotal developments that have caught the attention of investors...

Continue Reading
Forecasted Growth of US Unmanned Surface Vehicles Market

Updated Category News Views 105

Overview of the US Unmanned Surface Vehicles Market The US unmanned surface vehicles (USVs) market is on a remarkable trajectory, expected to reach $362.4 million by 2028. Estimated at $247.2 million in 2024, this signifies a robust compound annual growth rate (CAGR) of 9.5% throughout the forecast period. Enhancements in technology and an increasing reliance on USVs for...

Continue Reading
Understanding Balanced Commercial Property Trust Limited Disclosures

Updated Category News Views 173

Public Opening Position Disclosure Overview In the world of finance and investing, transparency is key. For companies like Balanced Commercial Property Trust Limited, adhering to disclosure regulations is vital. This article delves into the details surrounding public opening position disclosures and the responsibilities of significant shareholders as outlined under Rule...

Continue Reading
BCA Research Upgrades Auto Sector Boosted by Tesla Revival

Updated Category News Views 221

BCA Research Upgrades Auto Sector Amid Tesla’s Recovery BCA Research has recently elevated its perspective on the Auto & Components sector to an overweight position. This change is attributed to a notable resurgence led by Tesla's (NASDAQ: TSLA) surprising performance in the third quarter. Tesla's Dominance in the Auto Market Tesla continues to hold a substantial...

Continue Reading